|
[1]
|
StemCells Inc. (2012) Reports positive interim data from spinal cord injury trial. News Releases.
http://investor.stemcellsinc.com/phoenix.zhtml?c=86230&p=irol-newsArticle&ID=1730805&highlight=
|
|
[2]
|
Gupta, et al. (2012) Neural stem cell engraftment and myelination in the human brain. Science Translational Medicine, 4, 155ra137.
doi:10.1126/scitranslmed.3004373
|
|
[3]
|
Garbern, J.Y. (2006) Pelizaeus-Merzbacher disease: Genetic and cellular pathogenesis. Cellular and Molecular Life Sciences, 64, 50-65.
|
|
[4]
|
Giusto, E., Donegà, M., Cossetti, C. and Pluchino, S. (2006) Neuro-immune interactions of neural stem cell transplants: From animal disease models to human trials. Experimental Neurology, S0014-4886(13)00092-7.
doi:10.1016/j.expneurol.2013.03.009
|
|
[5]
|
Lo, B. and Parnham, L. (2009) Ethical issues in stem cell research. Endocrine Reviews, 30, 204-213.
doi:10.1210/er.2008-0031
|
|
[6]
|
English, K. and Wood, K.J. (2011) Immunogenicity of embryonic stem cell-derived progenitors after transplantation. Current Opinion in Organ Transplantation, 16, 90-95. doi:10.1097/MOT.0b013e3283424faa
|
|
[7]
|
Pan, G., Wang, T., Yao, H. and Pei, D. (2012) Somatic cell reprogramming for regenerative medicine: SCNT vs. iPS cells. Bioessays, 34, 472-476.
doi:10.1002/bies.201100174
|
|
[8]
|
UN (2005) 59/280—United nations declaration on human cloning.
http://daccess-dds-ny.un.org/doc/UNDOC/GEN/N04/493/06/PDF/N0449306.pdf?OpenElement
|
|
[9]
|
Mayor, S. (2005) UN committee approves declaration on human cloning. BMJ, 330, 496.
|
|
[10]
|
Stabile, B. (2007) Demographic profile of states with human cloning laws: Morality policy meets political economy. Politics and the Life Sciences, 26, 43-50.
doi:10.2990/26_1_43
|
|
[11]
|
Wang, S., Qu, X. and Zhao, R.C. (2012a) Clinical applications of mesenchymal stem cells. Journal of Hematology & Oncology, 5, 19. doi:10.1186/1756-8722-5-19
|
|
[12]
|
Griffin, M.D., Ritter, T. and Mahon, B.P. (2010) Immunological aspects of allogeneic mesenchymal stem cell therapies. Human Gene Therapy, 21, 1641-1655.
doi:10.1089/hum.2010.156
|
|
[13]
|
Griffin, M.D., Ryan, A.E., Alagesan, S., Lohan, P., Treacy, O. and Ritter, T. (2013) Anti-donor immune responses elicited by allogeneic mesenchymal stem cells: What have we learned so far? Immunology & Cell Biology, 91, 40-51. doi:10.1038/icb.2012.67
|
|
[14]
|
Choi, M.R., et al. (2012) Genome-scale DNA methylation pattern profiling of human bone marrow mesenchymal stem cells in long-term culture. Experimental & Molecular Medicine, 44, 503-512.
doi:10.3858/emm.2012.44.8.057
|
|
[15]
|
Capra, E., et al. (2012) Changes in the proteomic profile of adipose tissue-derived mesenchymal stem cells during passages. Proteome Science, 10, 46.
doi:10.1186/1477-5956-10-46
|
|
[16]
|
Brohlin, M., Kingham, P.J., Novikova, L.N., Novikov, L.N. and Wiberg, M. (2012) Aging effect on neurotrophic activity of human mesenchymal stem cells. PLoS One, 7, e45052. doi:10.1371/journal.pone.0045052
|
|
[17]
|
Lohmann, M., et al. (2012) Donor age of human platelet lysate affects proliferation and differentiation of mesenchymal stem cells. PLoS One, 7, e37839.
doi:10.1371/journal.pone.0037839
|
|
[18]
|
Takahashi, K. and Yamanaka, S. (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126, 663-676.
|
|
[19]
|
Yamanaka, et al. (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131, 861-872.
|
|
[20]
|
FDA (2012) Code of federal regulations title 21, part 1271 human cells, tissues, and cellular and tissue-based products. 66 fr 5466.
|
|
[21]
|
Zhou, W. and Freed, C.R. (2009) Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells. Stem Cells, 27, 2667-2674.
doi:10.1002/stem.201
|
|
[22]
|
Soldner, F., et al. (2009) Parkinson’s disease patientderived induced pluripotent stem cells free of viral reprogramming factors. Cell, 136, 964-977.
doi:10.1016/j.cell.2009.02.013
|
|
[23]
|
Yu, J.Y., et al. (2009) Human induced pluripotent stem cells free of vector and transgene sequences. Science, 324, 797-801.doi:10.1126/science.1172482
|
|
[24]
|
Jia, et al. (2010) A nonviral minicircle vector for deriving human iPS cells. Nature Methods, 7, 197-201.
doi:10.1038/nmeth.1426
|
|
[25]
|
Woltjen, et al. (2009) piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature, 458, 766-770. doi:10.1038/nature07863
|
|
[26]
|
Kaji, K., Norrby, K., Paca, A., Mileikovsky, M., Mohseni, P. and Woltjen, K. (2009) Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature, 458, 771-775. doi:10.1038/nature07864
|
|
[27]
|
Fusaki, N., Ban, H., Nishiyama, A., Saeki, K. and Hasegawa, M. (2009) Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proceedings of the Japan Academy. Series B, Physical and Biological Sciences, 85, 348-362.
|
|
[28]
|
Yakubov, E., Rechavi, G., Rozenblatt, S. and Givol, D. (2010) Reprogramming of human fibroblasts to pluripotent stem cells using mRNA of four transcription factors. Biochemical and Biophysical Research Communications, 394, 189-193. doi:10.1016/j.bbrc.2010.02.150
|
|
[29]
|
Warren, L., et al. (2010) Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell, 7, 618-630. doi:10.1016/j.stem.2010.08.012
|
|
[30]
|
Miyoshi, N., et al. (2011) Reprogramming of mouse and human cells to pluripotency using mature MicroRNAs. Cell Stem Cell, 8, 633-638.
doi:10.1016/j.stem.2011.05.001
|
|
[31]
|
Anokye-Danso, F., et al. (2011) Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell, 8, 376-388.
doi:10.1016/j.stem.2011.03.001
|
|
[32]
|
Kim, D., et al. (2009) Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell, 4, 472-476.
doi:10.1016/j.stem.2009.05.005
|
|
[33]
|
Esteban, M.A., et al. (2010) Vitamin C enhances the generation of mouse and human induced pluripotent stem cells. Cell Stem Cell, 6, 71-79.
doi:10.1016/j.stem.2009.12.001
|
|
[34]
|
Ichida, J.K., et al. (2009) A small-molecule inhibitor of tgf-B signaling replaces sox2 in reprogramming by inducing nanog. Cell Stem Cell, 5, 491-503.
doi:10.1016/j.stem.2009.09.012
|
|
[35]
|
Li, et al. (2012) Identification of Oct4-activating compounds that enhance reprogramming efficiency. Proceedings of the National Academy of Sciences, 109, 20853-20858. doi:10.1073/pnas.1219181110
|
|
[36]
|
Liu, W.B., et al. (2013) Mitochondrial metabolism transition cooperates with nuclear reprogramming during induced pluripotent stem cell generation. Biochemical and Biophysical Research Communications, 431, 767-771.
doi:10.1016/j.bbrc.2012.12.148
|
|
[37]
|
Mali, P., et al. (2010) Butyrate greatly enhances derivation of human induced pluripotent stem cells by promoting epigenetic remodeling and the expression of pluripotency-associated genes. Stem Cells, 28, 713-720.
|
|
[38]
|
Onder, T.T., et al. (2012) Chromatin-modifying enzymes as modulators of reprogramming. Nature, 483, 598-602.
|
|
[39]
|
Lin, T.X., et al. (2009) A chemical platform for improved induction of human iPSCs. Nature Methods, 6, 805-808.
|
|
[40]
|
Valamehr, B., et al. (2012) A novel platform to enable the high-throughput derivation and characterization of feeder-free human iPSCs. Scientific Reports, 2, 213.
doi:10.1038/srep00213
|
|
[41]
|
Wang, T., et al. (2011) The histone demethylases Jhdm1a/1b enhance somatic cell reprogramming in a vitamin-C-dependent manner. Cell Stem Cell, 9, 575-587.
doi:10.1016/j.stem.2011.10.005
|
|
[42]
|
Wang, Q., et al. (2011) Lithium, an anti-psychotic drug, greatly enhances the generation of induced pluripotent stem cells. Cell Research, 21, 1424-1435.
doi:10.1038/cr.2011.108
|
|
[43]
|
Zhu, S., Wei, W. and Ding, S. (2011) Chemical strategies for stem cell biology and regenerative medicine. Annual Review of Biomedical Engineering, 13, 73-90.
doi:10.1146/annurev-bioeng-071910-124715
|
|
[44]
|
Lister, R., et al. (2011) Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature, 471, 68-73.
|
|
[45]
|
Ruiz, S., et al. (2012) Identification of a specific reprogramming-associated epigenetic signature in human induced pluripotent stem cells. Proceedings of the National Academy of Sciences of the United States of America, 109, 16196-16201. doi:10.1073/pnas.1202352109
|
|
[46]
|
Suhr, S.T., et al. (2009) Telomere dynamics in human cells reprogrammed to pluripotency. PLoS One, 4, e8124. doi:10.1371/journal.pone.0008124
|
|
[47]
|
Prigione, A., Fauler, B., Lurz, R., Lehrach, H. and Adjaye, J. (2010) The senescence-related mitochondrial/oxidative stress pathway is repressed in human induced pluripotent stem cells. Stem Cells, 28, 721-733. doi:10.1002/stem.404
|
|
[48]
|
Suhr, S.T., et al. (2010) Mitochondrial rejuvenation after induced pluripotency. PLoS One, 5, e14095.
doi:10.1371/journal.pone.0014095
|
|
[49]
|
Yoneyama, M., et al. (2004) The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nature Immunology, 5, 730-737.
|
|
[50]
|
Angel, M. and Yanik, M.F. (2010) Innate immune suppression enables frequent transfection with RNA encoding reprogramming proteins. PLoS One, 5, e11756.
doi:10.1371/journal.pone.0011756
|
|
[51]
|
Warren, L., Ni, Y., Wang, J. and Guo, X. (2012) Feeder-free derivation of human induced pluripotent stem cells with messenger RNA. Scientific Reports, 2, 657.
doi:10.1038/srep00657
|
|
[52]
|
Their, M., Munst, B. and Edenhofer, F. (2010) Exploring refined conditions for reprogramming cells by recombinant Oct4 protein. The International Journal of Developmental Biology, 54, 1713-1721.
doi:10.1387/ijdb.103193mt
|
|
[53]
|
Their, M., Munst, B., Mielke, S. and Edenhofer, F. (2012) Cellular reprogramming employing recombinant Sox2 protein. Stem Cells International, 2012, Article ID: 549846. doi:10.1155/2012/549846
|
|
[54]
|
Hook, L., et al. (2011) Non-immortalized human neural stem (NS) cells as a scalable platform for cellular assays. Neurochemistry International, 59, 432-444.
doi:10.1016/j.neuint.2011.06.024
|
|
[55]
|
Singh, A., et al. (2013) Adhesion strength-based, labelfree isolation of human pluripotent stem cells. Nature Methods, 10, 438-444.
|
|
[56]
|
Street, C.A. and Bryan, B.A. (2011) Rho kinase proteins: Pleiotropic modulators of cell survival and apoptosis. Anticancer Research, 31, 3645-3657.
|
|
[57]
|
Hong, H., et al. (2009) Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature, 460, 1132-1135.
|
|
[58]
|
Yoshida, Y., Takahashi, K., Okita, K., Ichisaka, T. and Yamanaka, S. (2009) Hypoxia enhances the generation of induced pluripotent stem cells. Cell Stem Cell, 5, 237-241.
doi:10.1016/j.stem.2009.08.001
|
|
[59]
|
Covello, K.L., et al. (2006) HIF-2alpha regulates Oct-4: Effects of hypoxia on stem cell function, embryonic development, and tumor growth. Genes & Development, 20, 557-570. doi:10.1101/gad.1399906
|
|
[60]
|
Zhu, S.Y., et al. (2010) Reprogramming of human primary somatic cells by OCT4 and chemical compounds. Cell Stem Cell, 7, 651-655.
doi:10.1016/j.stem.2010.11.015
|
|
[61]
|
Staerk, J., et al. (2011) Pan-src family kinase inhibitors replace Sox2 during the direct reprogramming of somatic cells. Angewandte Chemie International Edition, 50, 5734-5736. doi:10.1002/anie.201101042
|
|
[62]
|
Lian, X., Selekman, J., Bao, X., Hsiao, C., Zhu, K. and Palecek, S.P. (2013) A small molecule inhibitor of src family kinases promotes simple epithelial differentiation of human pluripotent stem cells. PLoS One, 8, e60016. doi:10.1371/journal.pone.0060016
|
|
[63]
|
Kim, J.B., et al. (2009) Direct reprogramming of human neural stem cells by OCT4. Nature, 461, 649-653.
|
|
[64]
|
Hezroni, H., Sailaja, B.S. and Meshorer, E. (2011) Pluripotency-related, valproic acid (VPA)-induced genome-wide histone H3 Lysine 9 (H3K9) acetylation patterns in embryonic stem cells. The Journal of Biological Chemistry, 286, 35977-35988. doi:10.1074/jbc.M111.266254
|
|
[65]
|
Huangfu, D., et al. (2008) Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nature Biotechnology, 26, 1269-1275.
|
|
[66]
|
Wang, W.-P., et al. (2012) The EP300, KDM5A, KDM6A and KDM6B chromatin regulators cooperate with KLF4 in the transcriptional activation of POU5F1. PLoS One, 7, e52556. doi:10.1371/journal.pone.0052556
|
|
[67]
|
Shi, Y., Desponts, C., Do, J.T., Hahm, H.S., Schler, H.R. and Ding, S. (2008) Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Cell Stem Cell, 3, 568-574. doi:10.1016/j.stem.2008.10.004
|
|
[68]
|
Epsztejn-Litman, S., et al. (2008) De novo DNA methyllation promoted by G9a prevents reprogramming of embryonically silenced genes. Nature Structural & Molecular Biology, 15, 1176-1183.
|
|
[69]
|
Vedadi, M., et al. (2011) A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells. Nature Chemical Biology, 7, 566-574.
|
|
[70]
|
Chen, X.J., et al. (2012) G9a/GLP-dependent histone H3K9me2 patterning during human hematopoietic stem cell lineage commitment. Genes & Develoment, 26, 2499-2511. doi:10.1101/gad.200329.112
|
|
[71]
|
Brueckner, B., et al. (2005) Epigenetic reactivation of tumor suppressor genes by a novel small-molecule inhibitor of human DNA methyltransferases. Cancer Research, 65, 6305-6311.
doi:10.1158/0008-5472.CAN-04-2957
|
|
[72]
|
Niwa, H., Miyazaki, J. and Smith, A.G. (2000) Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nature Genetics, 24, 372-376.
|
|
[73]
|
You, J.S., Kelly, T.K., De Carvalho, D.D., Taberlay, P.C., Liang, G. and Jones, P.A. (2011) OCT4 establishes and maintains nucleosome-depleted regions that provide additional layers of epigenetic regulation of its target genes. Proceedings of the National Academy of Sciences of the United States of America, 108, 14497-14502.
doi:10.1073/pnas.1111309108
|
|
[74]
|
Bhutani, N., et al. (2013) A critical role for AID in the initiation of reprogramming to induced pluripotent stem cells. The FASEB Journal, 27, 1107-1113.
doi:10.1096/fj.12-222125
|
|
[75]
|
Chew, J.-L., et al. (2005) Reciprocal transcriptional regulation of Pou5f1 and Sox2 via the Oct4/Sox2 complex in embryonic stem cells. Molecular and Cellular Biology, 25, 6031-6046. doi:10.1128/MCB.25.14.6031-6046.2005
|
|
[76]
|
Adewumi, O., et al. (2007) Characterization of human embryonic stem cell lines by the international stem cell initiative. Nature Biotechnology, 25, 803-816.
doi:10.1038/nbt1318
|
|
[77]
|
Ghosh, Z., Wilson, K.D., Wu, Y., Hu, S., Quertermous, T. and Wu, J.C. (2010) Persistent donor cell gene expression among human induced pluripotent stem cells contributes to differences with human embryonic stem cells. PLoS One, 5, e8975. doi:10.1371/journal.pone.0008975
|
|
[78]
|
Chung, H.C., Lin, R.C., Logan, G.J., Alexander, I.E., Sachdev, P.S. and Sidhu, K.S. (2012) Human induced pluripotent stem cells derived under feeder-free conditions display unique cell cycle and DNA replication gene profiles. Stem Cells and Develoment, 21, 206-216.
doi:10.1089/scd.2010.0440
|
|
[79]
|
Ilic, D., et al. (2012) Derivation and feeder-free propagation of human embryonic stem cells under xeno-free conditions. Cytotherapy, 14, 122-128.
doi:10.3109/14653249.2011.623692
|
|
[80]
|
Baker, D.E.C., et al. (2007) Adaptation to culture of human embryonic stem cells and oncogenesis in vivo. Nature Biotechnology, 25, 207-215. doi:10.1038/nbt1285
|
|
[81]
|
Mayshar, Y., et al. (2010) Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell, 7, 521-531.
doi:10.1016/j.stem.2010.07.017
|
|
[82]
|
Gore, A., et al. (2011) Somatic coding mutations in human induced pluripotent stem cells. Nature, 471, 63-67.
|
|
[83]
|
Hussein, S.M., et al. (2011) Copy number variation and selection during reprogramming to pluripotency. Nature, 471, 58-62.
|
|
[84]
|
Jones, P.A. and Baylin, S.B. (2007) The epigenomics of cancer. Cell, 128, 683-692.
doi:10.1016/j.cell.2007.01.029
|
|
[85]
|
Semi, K., Matsuda, Y., Ohnishi, K. and Yamada, Y. (2013) Cellular reprogramming and cancer development. International Journal of Cancer, 132, 1240-1248.
doi:10.1002/ijc.27963
|
|
[86]
|
Watanabe, A., Yamada, Y. and Yamanaka, S. (2013) Epigenetic regulation in pluripotent stem cells: A key to breaking the epigenetic barrier. Philosophical Transactions of the Royal Society B, 368, Article ID: 20120292. doi:10.1098/rstb.2012.0292
|
|
[87]
|
Tsai, C.C., Su, P.F., Huang, Y.F., Yew, T.L. and Hung, S.C. (2012) Oct4 and nanog directly regulate Dnmt1 to maintain self-renewal and undifferentiated state in mesenchymal stem cells. Molecular Cell, 47, 169-182.
doi:10.1016/j.molcel.2012.06.020
|
|
[88]
|
Guo, X.D., et al. (2013) microRNA-29b is a novel mediator of Sox2 function in the regulation of somatic cell reprogramming. Cell Research, 23, 142-156.
doi:10.1038/cr.2012.180
|
|
[89]
|
Jin, B., Li, Y. and Robertson, K.D. (2011) DNA methylation: Superior or subordinate in the epigenetic hierarchy? Genes & Cancer, 2, 607-617.
doi:10.1177/1947601910393957
|
|
[90]
|
Lehnertz, B., et al. (2003) Suv39h-mediated histone H3 Lysine 9 methylation directs DNA methylation to major satellite repeats at pericentric heterochromatin. Current Biology, 13, 1192-1200.
doi:10.1016/S0960-9822(03)00432-9
|
|
[91]
|
Vire, E., et al. (2006) The polycomb group protein EZH2 directly controls DNA methylation. Nature, 439, 871-874.
|
|
[92]
|
Li, B.-Z., et al. (2011) Histone tails regulate DNA methylation by allosterically activating de novo methyltransferase. Cell Research, 21, 1172-1181.
doi:10.1038/cr.2011.92
|
|
[93]
|
Mansour, A.A.F., et al. (2012) The H3K27 demethylase Utx regulates somatic and germ cell epigenetic reprogramming. Nature, 488, 409-413.
|
|
[94]
|
Chaturvedi, C.-P., et al. (2012) Maintenance of gene silencing by the coordinate action of the H3K9 methyltransferase G9a/KMT1C and the H3K4 demethylase Jarid1a/KDM5A. Proceedings of the National Academy of Sciences of the United States of America, 109, 18845-18850. doi:10.1073/pnas.1213951109
|
|
[95]
|
Carey, B.W., et al. (2011) Reprogramming factor stoichiometry influences the epigenetic state and biological properties of induced pluripotent stem cells. Cell Stem Cell, 9, 588-598. doi:10.1016/j.stem.2011.11.003
|
|
[96]
|
Parsons, X.H. (2012) The dynamics of global chromatin remodeling are pivotal for tracking the normal pluripotency of human embryonic stem cells. Anatomy & Physiology, S3, Article ID: 002.
|
|
[97]
|
Soufi, A., Donahue, G. and Zaret, K.S. (2012) Facilitators and impediments of the pluripotency reprogramming factors’ initial engagement with the genome. Cell, 151, 994-1004. doi:10.1016/j.cell.2012.09.045
|
|
[98]
|
Tsai, C-C., et al. (2010) Overexpression of hTERT increases stem-like properties and decreases spontaneous differentiation in human mesenchymal stem cell lines. Journal of Biomedical Science, 17, 64.
doi:10.1186/1423-0127-17-64
|
|
[99]
|
Yehezkel, S., et al. (2011) Reprogramming of telomeric regions during the generation of human induced pluripotent stem cells and subsequent differentiation into fibroblast-like derivatives. Epigenetics, 6, 63-75.
doi:10.4161/epi.6.1.13390
|
|
[100]
|
Agarwal, S., et al. (2010) Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients. Nature, 464, 292-296.
|
|
[101]
|
Hoffmeyer, K., et al. (2012) Wnt/B-catenin signaling regulates telomerase in stem cells and cancer cells. Science, 336, 1549-1554. doi:10.1126/science.1218370
|
|
[102]
|
Wang, F., et al. (2011) Molecular insights into the heterogeneity of telomere reprogramming in induced pluripotent stem cells. Cell Research, 22, 757-768.
doi:10.1038/cr.2011.201
|
|
[103]
|
O’Callaghan, N.J. and Fenech, M. (2011) A quantitative PCR method for measuring absolute telomere length. Biological Procedures Online, 13, 3.
doi:10.1186/1480-9222-13-3
|